MaxCyte Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.4% | +13.3% | +35.2% | +140.7% | +78.3% | +70.8% | +35.9% | +89.5% | +69.2% | -5.5% | +19.2% | |
| – | -98.7% | +12,741.7% | +233.9% | +157.4% | +32.3% | +41.1% | +222.0% | +47.7% | +18.9% | -6.4% | -29.6% | |
| – | – | – | – | +142.8% | +24.8% | +52.4% | +203.1% | +37.9% | – | – | – | |
| – | – | -38.1% | -177.5% | – | – | -153.2% | – | – | – | -119.7% | – | |
| – | -35.7% | +131.5% | +178.7% | +16.4% | +79.1% | +63.0% | +85.0% | +381.9% | -80.0% | -55.4% | +7.1% | |
| – | -35.7% | +131.5% | +178.7% | +528.7% | – | -3,747.5% | +1,076.3% | -87.3% | – | -87.4% | +274.1% | |
| – | – | – | – | – | – | – | – | -98.8% | -90.7% | +70.6% | – | |
| – | – | – | – | -77.6% | +4,656.3% | -58.1% | +7,731.2% | -100.0% | – | – | – | |
| – | -115.3% | – | +101.4% | -99.1% | +5,328.0% | +134.8% | +712.1% | -98.8% | -25.8% | -4.1% | -68.1% | |
| – | -137.7% | – | +46.2% | -203.5% | – | -10.6% | +719.0% | -226.5% | – | -152.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.